Lv, M., Pei, X., Ding, Y., Zhou, Z., Deng, L., Liu, Z., Liu, J., Zhang, L., Jiang, Q., Zhang, X., Lu, X., Zhao, X., Liu, G., He, T., Huang, X., Zhao, X. (2025). Next-day manufactured CD19 CAR-T cells exhibit superior persistence compared to conventional CAR-T therapy in R/R B-ALL. Blood. https://doi.org/10.1182/blood-2025-2407